nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Loose stools—Auranofin—psoriatic arthritis	0.0654	0.0654	CcSEcCtD
Ceftibuten—Melaena—Auranofin—psoriatic arthritis	0.0353	0.0353	CcSEcCtD
Ceftibuten—Aplastic anaemia—Auranofin—psoriatic arthritis	0.034	0.034	CcSEcCtD
Ceftibuten—Pancytopenia—Auranofin—psoriatic arthritis	0.0216	0.0216	CcSEcCtD
Ceftibuten—Neutropenia—Auranofin—psoriatic arthritis	0.0212	0.0212	CcSEcCtD
Ceftibuten—Jaundice—Auranofin—psoriatic arthritis	0.0197	0.0197	CcSEcCtD
Ceftibuten—Haematuria—Auranofin—psoriatic arthritis	0.0193	0.0193	CcSEcCtD
Ceftibuten—Agranulocytosis—Auranofin—psoriatic arthritis	0.0189	0.0189	CcSEcCtD
Ceftibuten—Flatulence—Auranofin—psoriatic arthritis	0.0156	0.0156	CcSEcCtD
Ceftibuten—Dysgeusia—Auranofin—psoriatic arthritis	0.0155	0.0155	CcSEcCtD
Ceftibuten—Anorexia—Auranofin—psoriatic arthritis	0.0123	0.0123	CcSEcCtD
Ceftibuten—Dyspepsia—Auranofin—psoriatic arthritis	0.0114	0.0114	CcSEcCtD
Ceftibuten—Decreased appetite—Auranofin—psoriatic arthritis	0.0112	0.0112	CcSEcCtD
Ceftibuten—Constipation—Auranofin—psoriatic arthritis	0.011	0.011	CcSEcCtD
Ceftibuten—Aphasia—Methotrexate—psoriatic arthritis	0.0108	0.0108	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.0106	0.0106	CcSEcCtD
Ceftibuten—Urticaria—Auranofin—psoriatic arthritis	0.0103	0.0103	CcSEcCtD
Ceftibuten—Abdominal pain—Auranofin—psoriatic arthritis	0.0102	0.0102	CcSEcCtD
Ceftibuten—Candida infection—Triamcinolone—psoriatic arthritis	0.0101	0.0101	CcSEcCtD
Ceftibuten—Pruritus—Auranofin—psoriatic arthritis	0.00913	0.00913	CcSEcCtD
Ceftibuten—Diarrhoea—Auranofin—psoriatic arthritis	0.00883	0.00883	CcSEcCtD
Ceftibuten—Vomiting—Auranofin—psoriatic arthritis	0.00821	0.00821	CcSEcCtD
Ceftibuten—Rash—Auranofin—psoriatic arthritis	0.00814	0.00814	CcSEcCtD
Ceftibuten—Dermatitis—Auranofin—psoriatic arthritis	0.00813	0.00813	CcSEcCtD
Ceftibuten—Nausea—Auranofin—psoriatic arthritis	0.00767	0.00767	CcSEcCtD
Ceftibuten—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00751	0.00751	CcSEcCtD
Ceftibuten—Irritability—Methylprednisolone—psoriatic arthritis	0.00733	0.00733	CcSEcCtD
Ceftibuten—Hyperkinesia—Prednisone—psoriatic arthritis	0.00731	0.00731	CcSEcCtD
Ceftibuten—Vaginal inflammation—Methotrexate—psoriatic arthritis	0.00701	0.00701	CcSEcCtD
Ceftibuten—Melaena—Methotrexate—psoriatic arthritis	0.00684	0.00684	CcSEcCtD
Ceftibuten—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00682	0.00682	CcSEcCtD
Ceftibuten—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00682	0.00682	CcSEcCtD
Ceftibuten—Irritability—Dexamethasone—psoriatic arthritis	0.00667	0.00667	CcSEcCtD
Ceftibuten—Irritability—Betamethasone—psoriatic arthritis	0.00667	0.00667	CcSEcCtD
Ceftibuten—Vaginal infection—Methotrexate—psoriatic arthritis	0.00661	0.00661	CcSEcCtD
Ceftibuten—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.00658	0.00658	CcSEcCtD
Ceftibuten—Psychotic disorder—Prednisone—psoriatic arthritis	0.00594	0.00594	CcSEcCtD
Ceftibuten—Haemoglobin—Prednisolone—psoriatic arthritis	0.00582	0.00582	CcSEcCtD
Ceftibuten—Irritability—Prednisone—psoriatic arthritis	0.00581	0.00581	CcSEcCtD
Ceftibuten—Haemorrhage—Prednisolone—psoriatic arthritis	0.00579	0.00579	CcSEcCtD
Ceftibuten—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00536	0.00536	CcSEcCtD
Ceftibuten—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00534	0.00534	CcSEcCtD
Ceftibuten—Haemorrhage—Triamcinolone—psoriatic arthritis	0.00533	0.00533	CcSEcCtD
Ceftibuten—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00532	0.00532	CcSEcCtD
Ceftibuten—Neutropenia—Prednisone—psoriatic arthritis	0.00492	0.00492	CcSEcCtD
Ceftibuten—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00486	0.00486	CcSEcCtD
Ceftibuten—Haemoglobin—Betamethasone—psoriatic arthritis	0.00486	0.00486	CcSEcCtD
Ceftibuten—Irritability—Methotrexate—psoriatic arthritis	0.00485	0.00485	CcSEcCtD
Ceftibuten—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00483	0.00483	CcSEcCtD
Ceftibuten—Haemorrhage—Betamethasone—psoriatic arthritis	0.00483	0.00483	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00458	0.00458	CcSEcCtD
Ceftibuten—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00454	0.00454	CcSEcCtD
Ceftibuten—Convulsion—Prednisolone—psoriatic arthritis	0.00437	0.00437	CcSEcCtD
Ceftibuten—Haemoglobin—Prednisone—psoriatic arthritis	0.00423	0.00423	CcSEcCtD
Ceftibuten—Haemorrhage—Prednisone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Ceftibuten—Pancytopenia—Methotrexate—psoriatic arthritis	0.00417	0.00417	CcSEcCtD
Ceftibuten—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00412	0.00412	CcSEcCtD
Ceftibuten—Dysuria—Methotrexate—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Ceftibuten—Neutropenia—Methotrexate—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Ceftibuten—Convulsion—Triamcinolone—psoriatic arthritis	0.00402	0.00402	CcSEcCtD
Ceftibuten—Convulsion—Methylprednisolone—psoriatic arthritis	0.00401	0.00401	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Ceftibuten—Dry mouth—Triamcinolone—psoriatic arthritis	0.00386	0.00386	CcSEcCtD
Ceftibuten—Renal failure—Methotrexate—psoriatic arthritis	0.00385	0.00385	CcSEcCtD
Ceftibuten—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Ceftibuten—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00378	0.00378	CcSEcCtD
Ceftibuten—Haematuria—Methotrexate—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Ceftibuten—Insomnia—Prednisolone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Ceftibuten—Paraesthesia—Prednisolone—psoriatic arthritis	0.0037	0.0037	CcSEcCtD
Ceftibuten—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00366	0.00366	CcSEcCtD
Ceftibuten—Convulsion—Betamethasone—psoriatic arthritis	0.00365	0.00365	CcSEcCtD
Ceftibuten—Convulsion—Dexamethasone—psoriatic arthritis	0.00365	0.00365	CcSEcCtD
Ceftibuten—Haemoglobin—Methotrexate—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Ceftibuten—Haemorrhage—Methotrexate—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Ceftibuten—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Ceftibuten—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Ceftibuten—Insomnia—Triamcinolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Ceftibuten—Insomnia—Methylprednisolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Ceftibuten—Paraesthesia—Triamcinolone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Ceftibuten—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00339	0.00339	CcSEcCtD
Ceftibuten—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Ceftibuten—Agitation—Prednisone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Ceftibuten—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Ceftibuten—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Ceftibuten—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00332	0.00332	CcSEcCtD
Ceftibuten—Anorexia—Betamethasone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Ceftibuten—Anorexia—Dexamethasone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Ceftibuten—Urticaria—Prednisolone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Ceftibuten—Fatigue—Triamcinolone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Ceftibuten—Fatigue—Methylprednisolone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Ceftibuten—Convulsion—Prednisone—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Ceftibuten—Chills—Methotrexate—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Ceftibuten—Insomnia—Betamethasone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Ceftibuten—Insomnia—Dexamethasone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Ceftibuten—Paraesthesia—Betamethasone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Ceftibuten—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Ceftibuten—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Ceftibuten—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Ceftibuten—Dyspepsia—Betamethasone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Ceftibuten—Urticaria—Triamcinolone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Ceftibuten—Urticaria—Methylprednisolone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Ceftibuten—Dysgeusia—Methotrexate—psoriatic arthritis	0.003	0.003	CcSEcCtD
Ceftibuten—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Ceftibuten—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Ceftibuten—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Ceftibuten—Decreased appetite—Betamethasone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Ceftibuten—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Ceftibuten—Fatigue—Betamethasone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Ceftibuten—Fatigue—Dexamethasone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Ceftibuten—Anorexia—Prednisone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Ceftibuten—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Ceftibuten—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Ceftibuten—Urticaria—Betamethasone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Ceftibuten—Urticaria—Dexamethasone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Ceftibuten—Dizziness—Prednisolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Ceftibuten—Asthenia—Triamcinolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Ceftibuten—Abdominal pain—Betamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Ceftibuten—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Ceftibuten—Body temperature increased—Betamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Ceftibuten—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Ceftibuten—Asthenia—Methylprednisolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Ceftibuten—Insomnia—Prednisone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Ceftibuten—Paraesthesia—Prednisone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Ceftibuten—Pruritus—Triamcinolone—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Ceftibuten—Pruritus—Methylprednisolone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Ceftibuten—Convulsion—Methotrexate—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Ceftibuten—Dyspepsia—Prednisone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Ceftibuten—Decreased appetite—Prednisone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Ceftibuten—Rash—Prednisolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Ceftibuten—Dermatitis—Prednisolone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Ceftibuten—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Ceftibuten—Fatigue—Prednisone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Ceftibuten—Headache—Prednisolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Ceftibuten—Constipation—Prednisone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Ceftibuten—Dizziness—Triamcinolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Ceftibuten—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Ceftibuten—Dizziness—Methylprednisolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Ceftibuten—Asthenia—Dexamethasone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Ceftibuten—Asthenia—Betamethasone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Ceftibuten—Nausea—Prednisolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Ceftibuten—Pruritus—Dexamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Ceftibuten—Pruritus—Betamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Ceftibuten—Vomiting—Triamcinolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Ceftibuten—Vomiting—Methylprednisolone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Ceftibuten—Rash—Triamcinolone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Ceftibuten—Dermatitis—Triamcinolone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Ceftibuten—Anorexia—Methotrexate—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Ceftibuten—Rash—Methylprednisolone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Ceftibuten—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Ceftibuten—Urticaria—Prednisone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Ceftibuten—Headache—Triamcinolone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Ceftibuten—Headache—Methylprednisolone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Ceftibuten—Abdominal pain—Prednisone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Ceftibuten—Body temperature increased—Prednisone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Ceftibuten—Diarrhoea—Betamethasone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Ceftibuten—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Ceftibuten—Dizziness—Dexamethasone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Ceftibuten—Dizziness—Betamethasone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Ceftibuten—Insomnia—Methotrexate—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Ceftibuten—Nausea—Triamcinolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Ceftibuten—Paraesthesia—Methotrexate—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Ceftibuten—Nausea—Methylprednisolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Ceftibuten—Dyspnoea—Methotrexate—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Ceftibuten—Somnolence—Methotrexate—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Ceftibuten—Hypersensitivity—Prednisone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Ceftibuten—Dyspepsia—Methotrexate—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Ceftibuten—Vomiting—Dexamethasone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Ceftibuten—Vomiting—Betamethasone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Ceftibuten—Decreased appetite—Methotrexate—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Ceftibuten—Rash—Betamethasone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Ceftibuten—Rash—Dexamethasone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Ceftibuten—Dermatitis—Betamethasone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Ceftibuten—Dermatitis—Dexamethasone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Ceftibuten—Fatigue—Methotrexate—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Ceftibuten—Headache—Dexamethasone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Ceftibuten—Headache—Betamethasone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Ceftibuten—Asthenia—Prednisone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Ceftibuten—Pruritus—Prednisone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Ceftibuten—Diarrhoea—Prednisone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Ceftibuten—Nausea—Dexamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Ceftibuten—Nausea—Betamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Ceftibuten—Urticaria—Methotrexate—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Ceftibuten—Dizziness—Prednisone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Ceftibuten—Body temperature increased—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Ceftibuten—Abdominal pain—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Ceftibuten—Vomiting—Prednisone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Ceftibuten—Rash—Prednisone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Ceftibuten—Dermatitis—Prednisone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Ceftibuten—Headache—Prednisone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Ceftibuten—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Ceftibuten—Asthenia—Methotrexate—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Ceftibuten—Nausea—Prednisone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Ceftibuten—Pruritus—Methotrexate—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Ceftibuten—Diarrhoea—Methotrexate—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Ceftibuten—Dizziness—Methotrexate—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Ceftibuten—Vomiting—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Ceftibuten—Rash—Methotrexate—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Ceftibuten—Dermatitis—Methotrexate—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Ceftibuten—Headache—Methotrexate—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Ceftibuten—Nausea—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
